Acute limb ischemia and anticoagulation in patients with history of atrial fibrillation
dc.creator | Spanos K., Athanasoulas A., Argyriou C., Vassilopoulos I., Giannoukas A.D. | en |
dc.date.accessioned | 2023-01-31T09:59:51Z | |
dc.date.available | 2023-01-31T09:59:51Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 03929590 | |
dc.identifier.uri | http://hdl.handle.net/11615/79247 | |
dc.description.abstract | BACKGROUND: Atrial fibrillation (AF) is the commonest source of arterial embolization causing acute limb ischemia (ALI). The aim of this study was to assess the adherence of anticoagulation in AF patients and the treatment of underdiagnosed AF patients, presenting with ALI in our service and to evaluate the risk factors associated with morbidity and mortality. METHODS: A retrospective analysis of prospectively collected data was carried out from 115 limbs of 112 consecutive patients presenting with ALI of AF origin from 2008 until 2012 to a tertiary vascular service. RESULT S: The mean transfer time to hospital was 12±8.5 h. On admission, only half of the patients were aware of having AF and only 67% of those patients were receiving oral anticoagulants at the time of their admission. Nearly all patients who were on Vitamin K Antagonists (VKA) had sub-therapeutic levels preoperatively on admission (92%). The 30-day postoperative mortality and morbidity rates were 1.7% and 47% respectively. The lower limb amputation rate was 4.4% and was only associated with diabetes mellitus (DM) (P=0.009553). Reversible renal impairment was correlated with increased creatinine phosphokinase (CPK) blood levels on admission (P=0.038). CONCLUSIONS: A considerable number of patients with AF might still remain without proper anticoagulation. DM increases the risk of lower limb loss after ALI. Development of renal impairment after thromboembolectomy for ALI is more likely in the presence of elevated CPK blood levels on admission. © 2015 EDIZIONI MINER VA MEDICA. | en |
dc.language.iso | en | en |
dc.source | International Angiology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84982949231&partnerID=40&md5=c90d73303278dfb4858d91c102971c41 | |
dc.subject | anticoagulant agent | en |
dc.subject | antivitamin K | en |
dc.subject | creatine kinase | en |
dc.subject | low molecular weight heparin | en |
dc.subject | anticoagulant agent | en |
dc.subject | biological marker | en |
dc.subject | creatine kinase | en |
dc.subject | abdominal aorta aneurysm | en |
dc.subject | acute disease | en |
dc.subject | acute kidney failure | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | anticoagulant therapy | en |
dc.subject | Article | en |
dc.subject | atrial fibrillation | en |
dc.subject | brain ischemia | en |
dc.subject | cerebrovascular disease | en |
dc.subject | chronic obstructive lung disease | en |
dc.subject | clinical evaluation | en |
dc.subject | clinical feature | en |
dc.subject | coronary artery disease | en |
dc.subject | creatine kinase blood level | en |
dc.subject | diabetes mellitus | en |
dc.subject | diabetic patient | en |
dc.subject | disease association | en |
dc.subject | disease duration | en |
dc.subject | dyslipidemia | en |
dc.subject | electrolyte disturbance | en |
dc.subject | female | en |
dc.subject | heart disease | en |
dc.subject | heparinization | en |
dc.subject | hospital admission | en |
dc.subject | human | en |
dc.subject | hypertension | en |
dc.subject | leg amputation | en |
dc.subject | leg ischemia | en |
dc.subject | limb ischemia | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | medical history | en |
dc.subject | medication compliance | en |
dc.subject | morbidity | en |
dc.subject | mortality | en |
dc.subject | mortality risk | en |
dc.subject | patient compliance | en |
dc.subject | patient transport | en |
dc.subject | peroperative complication | en |
dc.subject | postoperative complication | en |
dc.subject | retrospective study | en |
dc.subject | smoking | en |
dc.subject | upper limb | en |
dc.subject | very elderly | en |
dc.subject | acute disease | en |
dc.subject | adverse effects | en |
dc.subject | atrial fibrillation | en |
dc.subject | blood | en |
dc.subject | complication | en |
dc.subject | diabetes mellitus | en |
dc.subject | embolectomy | en |
dc.subject | Greece | en |
dc.subject | ischemia | en |
dc.subject | Kidney Diseases | en |
dc.subject | middle aged | en |
dc.subject | risk factor | en |
dc.subject | tertiary care center | en |
dc.subject | thrombectomy | en |
dc.subject | time factor | en |
dc.subject | treatment outcome | en |
dc.subject | Acute Disease | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Anticoagulants | en |
dc.subject | Atrial Fibrillation | en |
dc.subject | Biomarkers | en |
dc.subject | Creatine Kinase | en |
dc.subject | Diabetes Mellitus | en |
dc.subject | Embolectomy | en |
dc.subject | Female | en |
dc.subject | Greece | en |
dc.subject | Humans | en |
dc.subject | Ischemia | en |
dc.subject | Kidney Diseases | en |
dc.subject | Male | en |
dc.subject | Medication Adherence | en |
dc.subject | Middle Aged | en |
dc.subject | Retrospective Studies | en |
dc.subject | Risk Factors | en |
dc.subject | Tertiary Care Centers | en |
dc.subject | Thrombectomy | en |
dc.subject | Time Factors | en |
dc.subject | Treatment Outcome | en |
dc.subject | Edizioni Minerva Medica | en |
dc.title | Acute limb ischemia and anticoagulation in patients with history of atrial fibrillation | en |
dc.type | journalArticle | en |
Dateien zu dieser Ressource
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |